O	O	O	0	14	Identification	Identification	B-NP	NN	O	3	NMOD	O
O	O	O	15	18	and	and	I-NP	CC	O	3	NMOD	O
O	O	O	19	35	characterization	characterization	I-NP	NN	O	0	ROOT	O
O	O	O	36	38	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	39	40	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	41	50	leukocyte	leukocyte	I-NP	NN	B-cell_type	9	NMOD	B-cell_type
O	O	O	50	51	-	-	B-NP	HYPH	O	9	NMOD	O
O	O	O	51	59	specific	specific	I-NP	JJ	O	9	NMOD	O
O	O	O	60	69	component	component	I-NP	NN	O	4	PMOD	O
O	O	O	70	72	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	73	76	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	77	84	nuclear	nuclear	I-NP	JJ	O	13	NMOD	O
O	O	O	85	89	body	body	I-NP	NN	O	10	PMOD	O
O	O	O	89	90	.	.	O	.	O	3	P	O

O	O	O	92	95	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	96	103	nuclear	nuclear	I-NP	JJ	O	3	NMOD	O
O	O	O	104	108	body	body	I-NP	NN	O	7	SUB	O
O	O	O	109	110	(	(	O	(	O	6	DEP	O
O	O	O	110	112	NB	NB	B-NP	NN	O	6	DEP	O
O	O	O	112	113	)	)	O	)	O	3	NMOD	O
O	O	O	114	116	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	117	118	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	119	127	cellular	cellular	I-NP	JJ	O	10	NMOD	O
O	O	O	128	137	organelle	organelle	I-NP	NN	O	7	PRD	O
O	O	O	138	142	that	that	B-NP	WDT	O	10	NMOD	O
O	O	O	143	145	is	be	B-VP	VBZ	O	11	SBAR	O
O	O	O	146	154	involved	involve	I-VP	VBN	O	12	VC	O
O	O	O	155	157	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	158	161	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	162	174	pathogenesis	pathogenesis	I-NP	NN	O	14	PMOD	O
O	O	O	175	177	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	178	183	acute	acute	B-NP	JJ	O	20	NMOD	O
O	O	O	184	197	promyelocytic	promyelocytic	I-NP	JJ	O	20	NMOD	O
O	O	O	198	206	leukemia	leukemia	I-NP	NN	O	23	NMOD	O
O	O	O	207	210	and	and	O	CC	O	23	NMOD	O
O	O	O	211	216	viral	viral	B-NP	JJ	O	23	NMOD	O
O	O	O	217	226	infection	infection	I-NP	NN	O	17	PMOD	O
O	O	O	226	227	.	.	O	.	O	7	P	O

O	O	O	228	231	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	232	234	NB	NB	I-NP	NN	O	3	SUB	O
O	O	O	235	237	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	238	242	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	O	243	244	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	245	251	target	target	I-NP	NN	O	3	PRD	O
O	O	O	252	254	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	255	265	antibodies	antibody	B-NP	NNS	B-protein	7	PMOD	B-protein
O	O	O	266	268	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	269	272	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	273	278	serum	serum	I-NP	NN	O	9	PMOD	O
O	O	O	279	281	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	282	290	patients	patient	B-NP	NNS	O	12	PMOD	O
O	O	O	291	295	with	with	B-PP	IN	O	13	NMOD	O
O	O	O	296	299	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	300	310	autoimmune	autoimmune	I-NP	JJ	O	20	NMOD	O
O	O	O	311	318	disease	disease	I-NP	NN	O	20	NMOD	O
O	O	O	319	326	primary	primary	B-NP	JJ	O	20	NMOD	O
O	O	O	327	334	biliary	biliary	I-NP	JJ	O	20	NMOD	O
O	O	O	335	344	cirrhosis	cirrhosis	I-NP	NN	O	14	PMOD	O
O	O	O	344	345	.	.	O	.	O	3	P	O

O	O	O	346	348	In	In	B-PP	IN	O	13	VMOD	O
O	O	O	349	353	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	354	359	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	359	360	,	,	O	,	O	13	P	O
O	O	O	361	366	serum	serum	B-NP	NN	O	13	SUB	O
O	O	O	367	371	from	from	B-PP	IN	O	5	NMOD	O
O	O	O	372	373	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	374	381	patient	patient	I-NP	NN	O	6	PMOD	O
O	O	O	382	386	with	with	B-PP	IN	O	8	NMOD	O
O	O	O	387	394	primary	primary	B-NP	JJ	O	12	NMOD	O
O	O	O	395	402	biliary	biliary	I-NP	JJ	O	12	NMOD	O
O	O	O	403	412	cirrhosis	cirrhosis	I-NP	NN	O	9	PMOD	O
O	O	O	413	416	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	417	421	used	use	I-VP	VBN	O	13	VC	O
O	O	O	422	424	to	to	B-VP	TO	O	16	VMOD	O
O	O	O	425	433	identify	identify	I-VP	VB	O	14	VMOD	O
O	O	O	434	435	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	436	440	cDNA	cDNA	I-NP	NN	B-DNA	16	OBJ	B-DNA
O	O	O	441	449	encoding	encode	B-VP	VBG	O	18	NMOD	O
O	O	O	450	451	a	a	B-NP	DT	O	22	NMOD	O
O	O	O	452	457	novel	novel	I-NP	JJ	O	22	NMOD	O
O	O	O	458	467	component	component	I-NP	NN	O	31	NMOD	O
O	O	O	468	470	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	471	474	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	475	477	NB	NB	I-NP	NN	O	23	PMOD	O
O	O	O	477	478	,	,	O	,	O	31	P	O
O	O	O	479	480	a	a	B-NP	DT	O	31	NMOD	O
O	O	O	481	484	140	140	I-NP	CD	B-protein	31	NMOD	B-protein
O	O	O	484	485	-	-	I-NP	HYPH	I-protein	31	NMOD	I-protein
O	O	O	485	488	kDa	kDa	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	489	496	protein	protein	I-NP	NN	I-protein	19	OBJ	I-protein
O	O	O	497	507	designated	designate	B-VP	VBN	O	31	NMOD	O
T1	B-Protein	B-Protein	508	513	Sp140	Sp140	B-NP	NN	B-protein	32	VMOD	B-protein
O	O	O	513	514	.	.	O	.	O	13	P	O

O	O	O	515	518	The	The	B-NP	DT	O	5	NMOD	O
O	O	O	519	528	predicted	predict	I-NP	VBN	O	5	NMOD	O
O	O	O	529	534	amino	amino	I-NP	NN	O	5	NMOD	O
O	O	O	535	539	acid	acid	I-NP	NN	O	5	NMOD	O
O	O	O	540	548	sequence	sequence	I-NP	NN	O	14	SUB	O
O	O	O	549	551	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	552	555	the	the	B-NP	DT	O	11	NMOD	O
T10	B-Entity	B-Entity	556	561	amino	amino	I-NP	JJ	B-protein	11	NMOD	B-protein
T10	I-Entity	I-Entity	561	562	-	-	I-NP	HYPH	I-protein	11	NMOD	I-protein
T10	I-Entity	I-Entity	562	570	terminal	terminal	I-NP	JJ	I-protein	11	NMOD	I-protein
T10	I-Entity	I-Entity	571	578	portion	portion	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	579	581	of	of	B-PP	IN	O	11	NMOD	O
T2	B-Protein	B-Protein	582	587	Sp140	Sp140	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	O	588	591	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	592	599	similar	similar	B-ADJP	JJ	O	14	PRD	O
O	O	O	600	602	to	to	B-PP	TO	O	15	AMOD	O
T3	B-Protein	B-Protein	603	608	Sp100	Sp100	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	608	609	,	,	O	,	O	23	P	O
O	O	O	610	611	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	612	622	previously	previously	I-NP	RB	O	21	AMOD	O
O	O	O	623	633	identified	identify	I-NP	VBN	O	23	NMOD	O
O	O	O	634	636	NB	NB	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	637	644	protein	protein	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	O	644	645	.	.	O	.	O	14	P	O

O	O	O	646	649	The	The	B-NP	DT	O	3	NMOD	O
T11	B-Entity	B-Entity	650	658	carboxyl	carboxyl	I-NP	NN	B-protein	3	NMOD	B-protein
T11	I-Entity	I-Entity	659	666	portion	portion	I-NP	NN	I-protein	6	SUB	I-protein
O	O	O	667	669	of	of	B-PP	IN	O	3	NMOD	O
T4	B-Protein	B-Protein	670	675	Sp140	Sp140	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	O	676	685	contained	contain	B-VP	VBD	O	0	ROOT	O
O	O	O	686	687	a	a	B-NP	DT	O	11	NMOD	O
T12	B-Entity	B-Entity	688	692	zinc	zinc	I-NP	NN	B-protein	11	NMOD	B-protein
T12	I-Entity	I-Entity	692	693	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T12	I-Entity	I-Entity	693	699	finger	finger	I-NP	NN	I-protein	11	NMOD	I-protein
T12	I-Entity	I-Entity	700	706	domain	domain	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	707	710	and	and	O	CC	O	14	NMOD	O
O	O	O	711	712	a	a	B-NP	DT	O	14	NMOD	O
T13	B-Entity	B-Entity	713	724	bromodomain	bromodomain	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	724	725	,	,	O	,	O	16	P	O
O	O	O	726	732	motifs	motif	B-NP	NNS	O	6	OBJ	O
O	O	O	733	737	that	that	B-NP	WDT	O	16	NMOD	O
O	O	O	738	741	are	be	B-VP	VBP	O	17	SBAR	O
O	O	O	742	749	present	present	B-ADJP	JJ	O	18	PRD	O
O	O	O	750	752	in	in	B-PP	IN	O	19	AMOD	O
O	O	O	753	761	proteins	protein	B-NP	NNS	O	20	PMOD	O
O	O	O	762	772	regulating	regulate	B-VP	VBG	O	21	NMOD	O
O	O	O	773	777	gene	gene	B-NP	NN	O	24	NMOD	O
O	O	O	778	791	transcription	transcription	I-NP	NN	O	22	OBJ	O
O	O	O	791	792	.	.	O	.	O	6	P	O

O	O	O	793	797	High	High	B-NP	JJ	O	2	NMOD	O
O	O	O	798	804	levels	level	I-NP	NNS	O	6	SUB	O
O	O	O	805	807	of	of	B-PP	IN	O	2	NMOD	O
T5	B-Protein	B-Protein	808	813	Sp140	Sp140	B-NP	NN	B-RNA	5	NMOD	B-RNA
O	O	O	814	818	mRNA	mRNA	I-NP	NN	I-RNA	3	PMOD	I-RNA
O	O	O	819	823	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	824	832	detected	detect	I-VP	VBN	O	6	VC	O
O	O	O	833	835	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	836	841	human	human	B-NP	JJ	O	14	NMOD	O
O	O	O	842	848	spleen	spleen	I-NP	NN	O	14	NMOD	O
O	O	O	849	852	and	and	O	CC	O	14	NMOD	O
O	O	O	853	863	peripheral	peripheral	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	864	869	blood	blood	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	870	880	leukocytes	leukocyte	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	O	880	881	,	,	O	,	O	7	P	O
O	O	O	882	885	but	but	O	CC	O	7	VMOD	O
O	O	O	886	889	not	not	O	RB	O	7	VMOD	O
O	O	O	890	895	other	other	B-NP	JJ	O	20	NMOD	O
O	O	O	896	901	human	human	I-NP	JJ	O	20	NMOD	O
O	O	O	902	909	tissues	tissue	I-NP	NNS	O	7	VMOD	O
O	O	O	909	910	.	.	O	.	O	6	P	O

O	O	O	911	914	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	915	920	level	level	I-NP	NN	O	15	SUB	O
O	O	O	921	923	of	of	B-PP	IN	O	2	NMOD	O
T6	B-Protein	B-Protein	924	929	SP140	SP140	B-NP	NN	B-RNA	5	NMOD	B-RNA
O	O	O	930	934	mRNA	mRNA	I-NP	NN	I-RNA	3	PMOD	I-RNA
O	O	O	935	937	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	938	945	myeloid	myeloid	B-NP	JJ	B-cell_line	10	NMOD	B-cell_line
O	O	O	946	955	precursor	precursor	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	956	960	cell	cell	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	961	966	lines	line	I-NP	NNS	I-cell_line	6	PMOD	I-cell_line
O	O	O	967	971	HL60	HL60	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	O	972	975	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	976	979	NB4	NB4	I-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	980	988	markedly	markedly	B-ADVP	RB	O	15	VMOD	O
O	O	O	989	998	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	O	999	1001	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	1002	1010	response	response	B-NP	NN	O	16	PMOD	O
O	O	O	1011	1013	to	to	B-PP	TO	O	16	PMOD	O
O	O	O	1014	1024	chemically	chemically	B-NP	RB	O	20	AMOD	O
O	O	O	1025	1032	induced	induce	I-NP	VBN	O	22	NMOD	O
O	O	O	1033	1041	cellular	cellular	I-NP	JJ	O	22	NMOD	O
O	O	O	1042	1057	differentiation	differentiation	I-NP	NN	O	16	PMOD	O
O	O	O	1057	1058	.	.	O	.	O	15	P	O

O	O	O	1059	1078	Immunohistochemical	Immunohistochemical	B-NP	JJ	O	2	NMOD	O
O	O	O	1079	1089	techniques	technique	I-NP	NNS	O	3	SUB	O
O	O	O	1090	1094	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1095	1099	used	use	I-VP	VBN	O	3	VC	O
O	O	O	1100	1102	to	to	B-VP	TO	O	6	VMOD	O
O	O	O	1103	1114	demonstrate	demonstrate	I-VP	VB	O	4	VMOD	O
O	O	O	1115	1119	that	that	B-SBAR	IN	O	6	VMOD	O
T7	B-Protein	B-Protein	1120	1125	SP140	SP140	B-NP	NN	B-protein	9	SUB	B-protein
O	O	O	1126	1135	localized	localize	B-VP	VBD	O	7	SBAR	O
O	O	O	1136	1138	to	to	B-PP	TO	O	9	VMOD	O
O	O	O	1139	1142	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1143	1145	NB	NB	I-NP	NN	O	10	PMOD	O
O	O	O	1146	1148	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	1149	1163	differentiated	differentiate	B-NP	VBN	O	18	NMOD	O
O	O	O	1164	1168	HL60	HL60	I-NP	NN	B-cell_line	18	NMOD	B-cell_line
O	O	O	1169	1172	and	and	I-NP	CC	O	18	NMOD	O
O	O	O	1173	1176	NB4	NB4	I-NP	NN	B-cell_line	18	NMOD	B-cell_line
O	O	O	1177	1182	cells	cell	I-NP	NNS	I-cell_line	13	PMOD	I-cell_line
O	O	O	1182	1183	.	.	O	.	O	3	P	O

O	O	O	1184	1187	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1188	1196	location	location	I-NP	NN	O	10	NMOD	O
O	O	O	1197	1199	of	of	B-PP	IN	O	2	NMOD	O
T8	B-Protein	B-Protein	1200	1205	Sp140	Sp140	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	O	1206	1208	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	1209	1212	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1213	1215	NB	NB	I-NP	NN	O	5	PMOD	O
O	O	O	1215	1216	,	,	O	,	O	10	P	O
O	O	O	1217	1220	and	and	O	CC	O	10	NMOD	O
O	O	O	1221	1231	expression	expression	B-NP	NN	O	21	SUB	O
O	O	O	1232	1234	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1235	1239	this	this	B-NP	DT	O	13	NMOD	O
O	O	O	1240	1244	gene	gene	I-NP	NN	O	11	PMOD	O
O	O	O	1245	1247	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	1248	1253	cells	cell	B-NP	NNS	O	14	PMOD	O
O	O	O	1254	1262	involved	involve	B-VP	VBN	O	15	NMOD	O
O	O	O	1263	1265	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	1266	1270	host	host	B-NP	NN	O	19	NMOD	O
O	O	O	1271	1278	defense	defense	I-NP	NN	O	17	PMOD	O
O	O	O	1278	1279	,	,	O	,	O	10	P	O
O	O	O	1280	1287	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1288	1292	that	that	B-SBAR	IN	O	21	VMOD	O
T9	B-Protein	B-Protein	1293	1298	Sp140	Sp140	B-NP	NN	B-protein	24	SUB	B-protein
O	O	O	1299	1302	may	may	B-VP	MD	O	22	SBAR	O
O	O	O	1303	1305	be	be	I-VP	VB	O	24	VC	O
O	O	O	1306	1314	involved	involve	I-VP	VBN	O	25	VC	O
O	O	O	1315	1317	in	in	B-PP	IN	O	26	VMOD	O
O	O	O	1318	1321	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	1322	1334	pathogenesis	pathogenesis	I-NP	NN	O	27	PMOD	O
O	O	O	1335	1337	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	1338	1343	acute	acute	B-NP	JJ	O	33	NMOD	O
O	O	O	1344	1357	promyelocytic	promyelocytic	I-NP	JJ	O	33	NMOD	O
O	O	O	1358	1366	leukemia	leukemia	I-NP	NN	O	36	NMOD	O
O	O	O	1367	1370	and	and	O	CC	O	36	NMOD	O
O	O	O	1371	1376	viral	viral	B-NP	JJ	O	36	NMOD	O
O	O	O	1377	1386	infection	infection	I-NP	NN	O	30	PMOD	O
O	O	O	1386	1387	.	.	O	.	O	21	P	O
